TCVYX | VMVIX | TCVYX / VMVIX | |
Total Expense Ratio | 0.94 | 0.19 | 495% |
Annual Report Gross Expense Ratio | 1.10 | 0.19 | 579% |
Fund Existence | 16 years | 19 years | - |
Gain YTD | 4.336 | 5.177 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 562M | 31B | 2% |
Annual Yield % from dividends | 0.62 | 2.10 | 30% |
Returns for 1 year | 1.58 | 7.67 | 21% |
Returns for 3 years | 1.30 | 17.46 | 7% |
Returns for 5 years | 37.41 | 65.08 | 57% |
Returns for 10 years | 45.43 | 87.80 | 52% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PBE | 67.81 | 0.63 | +0.93% |
Invesco Biotechnology & Genome ETF | |||
MARO | 18.40 | 0.11 | +0.60% |
Yieldmax Mara Option Income Strategy ETF | |||
DYLD | 22.66 | N/A | N/A |
LeaderShares® Dynamic Yield ETF | |||
CHY | 10.84 | -0.03 | -0.28% |
Calamos Convertible and High Income Fund | |||
IWM | 227.13 | -1.11 | -0.49% |
iShares Russell 2000 ETF |